Use of 3,4-Diaminopyridine in the Treatment of Lambert-Eaton Syndrome

NCT01825395 · clinicaltrials.gov ↗
APPROVED_FOR_MARKETING
Status
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Colorado, Denver